Genentech Announces FDA Approval of ACTPen 162mg/0.9mL for Actemra

November 26, 2018 11:38 AM EST Send to a Friend
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login